OpenEye Scientific Software, Inc. Release: ROCS Outperforms Docking for 3D Virtual Screening in Merck & Co., Inc. Study

SANTA FE, N.M.--(BUSINESS WIRE)--OpenEye Scientific Software, Inc., the developer of innovative molecular modeling and cheminformatics solutions for drug discovery research, announced today that its 3D shape-based overlay and similarity application ROCS was reported to outperform a panel of docking tools in an independent virtual screening study published by Merck scientists [1].

Back to news